Annual Report

CERTs Project Partners

We gratefully acknowledge the following organizations for their expertise and support of CERTs research and education projects:

Academic Medicine and Managed Care Forum

AccessCare, Inc.

Advanced Medical Technology Association

Aetna Inc.

Agency for Healthcare Research and Quality

Agouron Pharmaceuticals, Inc.

Alabama Chapter of the American College of Physicians

Alabama Department of Public Health

Alabama Practice-based Continuing Medical Education and Research Network

Alacare Home Health Care

American Academy of Family Physicians

American Academy of Pediatrics

American Association of Colleges of Pharmacy

American College of Cardiology

American College of Clinical Pharmacy

American College of Rheumatology

American Heart Association

American Pharmaceutical Association Foundation

American Pharmacists Association

America's Health Insurance Plans

Amgen

Arizona Area Health Education Centers

Arthritis Foundation

Arthritis Foundation, Alabama Chapter

Arthritis Foundation, Maryland Chapter

AstraZeneca

Aventis, Inc.

Berlex, Inc.

Blue Cross/Blue Shield of Alabama

Bowman Gray School of Medicine

Brigham and Women's Hospital

Bristol-Myers Squibb Company

Bureau of TennCare

Cancer Research Network

Caremark

Carolina Medical Review

Center for Health Care Policy and Evaluation/UnitedHealth Group

Centers for Disease Control and Prevention

Centers for Disease Control and Prevention Foundation

Centers for Medicare & Medicaid Services

Children's National Medical Center

Cincinnati Children's Hospital Medical Center

Columbus Children's Hospital

Community Cares of North Carolina

Community Health Centers

Computer Sciences Corporation (CSC)/Clinical Data Abstraction Center (CDAC)

Conceptis Technologies

Council for Affordable Quality Healthcare

Critical Path Institute (The)

Crohn's & Colitis Foundation of America

Department of Veterans Affairs

Duke Clinical Research Institute

Duke Educational Media Services

Duke Heart Center

Duke Infection Control Outreach Network

Duke University Department of Psychology

Duke University Health System

Eli Lilly and Company

Express Scripts, Inc.

Fallon Community Health Plan

Genentech, Inc.

General Practice Research

Database/EPIC

Georgetown University

GlaxoSmithKline

Group Health Cooperative of Puget Sound

Harvard Pilgrim Health Care

Harvard School of Medicine

Harvard School of Public Health

Harvard Vanguard Medical Associates

Health Resources and Services Administration

HealthPartners

Henry Ford Health System

IMS Health

Infectious Diseases Society of America

Institute for Healthcare Improvement

Institute of Medicine

Integrative Pain Center of Arizona

International Society for Pharmacoepidemiology

Iowa Women's Health Study

Janssen Pharmaceutica

John A. Hartford Foundation

Kaiser Permanente Colorado

Kaiser Permanente Georgia

Kaiser Permanente Northern California

Kaiser Permanente Northwest

Kaiser Permanente Southern California

La Frontera Hope Center

Lincoln Technologies

Massachusetts Department of Public Health

Massachusetts Division of Medical Assistance

Medco Health Solutions

Medical Review of North Carolina, Inc.

Medtronic MiniMed, Inc.

Merck

Nanogen, Inc.

National Committee for Quality Assurance

National Foundation for Infectious Diseases

National Health and Medical Research Council Clinical Trials Centre, Sydney, Australia

National Initiative for Children's Healthcare Quality

National Institutes of Health/National Cancer Institute

National Institutes of Health/National Institute of Allergy and Infectious Diseases

National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases

National Institutes of Health/National Institute of Diabetes & Digestive & Kidney Diseases

National Institutes of Health/National Institute of General Medical Sciences

National Institutes of Health/National Institute of Mental Health

National Institutes of Health/National Institute of Nursing Research

National Institutes of Health/National Institute on Aging

National Institutes of Health/Office of Research on Women's Health

National Patient Safety Foundation

North Carolina Access Care

North Carolina Area Health Education Centers

North Carolina Association of Pharmacists

North Carolina Center for Children's Healthcare Improvement

North Carolina Department of Health and Human Services

North Carolina Medicaid

North Carolina State Children's Health Insurance Program

North Carolina Women, Infants, and Children Program

Ortho-McNeil Pharmaceutical, Inc.

Parke-Davis Pharmaceutical

Pediatric Research in office Settings

Penn Center for AIDS Research

Pennsylvania Department of Public Health

Pennsylvania Pharmaceutical

Assistance Contract for the Elderly

Pfizer Inc.

Pharmaceutical Research and Manufacturers of America

Pharmacia & Upjohn

Pharmacogenetics Network

Premier

Proctor and Gamble

ProVantage Health Services, Inc.

QED Solutions, Incorporated

Reliant Pharmaceuticals, Inc.

Robert Wood Johnson Foundation

Roche Laboratories, Inc.

RTI Health Solutions

RTI International

SAS

Society for Healthcare Epidemiology of America

Society for Women's Health Research

Society of Thoracic Surgeons

South Carolina Office of Research and Statistics

Southeastern Regional Osteoporosis Board

TAP Pharmaceutical Products, Inc.

Tennessee Department of Health

UCLA/RAND Center for Adolescent Health Promotion

U.S. Department of Health and Human Services/Office on Women's Health

U.S. Food and Drug Administration

U.S. Food and Drug Administration/Office of Women's Health

U.S. Public Health Service

U.S. Quality Algorithms, Inc.

United Mine Workers of America Health and Retirement Funds

United States Pharmacopeial Convention, Inc.

United Healthcare of Alabama

University of Arizona Department of Communication

University of Arizona National Center of Excellence in Women's Health

University of Arizona Poison and Drug Information Center

University of Illinois at Chicago

University of Massachusetts Medical School

University of Pennsylvania Health System

University of Pennsylvania School of Medicine

University of Texas Health Science Center at San Antonio

University of Washington

Wake Forest Baptist Medical Center

Walgreens Co.

WellPoint, Inc.

Whitehall-Robbins Inc.

Wyeth

Wyeth-Ayerst Laboratories

Peer-Reviewed Publications:

October 1, 2005-September 30, 2006

Referenced Publications

1. Johnson L, Strich H, Taylor A, Timmermann B, Malone D, Teufel-Shone N, Drummond R, Woosley R, Pereira E, Martinez A. Use of herbal remedies by diabetic Hispanic women in the southwestern United States. Phytother Res 2006;20:250-5.

2. MacAdam H, Zaoutis TE, Gasink LB, Bilker WB, Lautenbach E. Investigating the association between antibiotic use and antibiotic resistance: impact of different methods of categorising prior antibiotic use. Int J Antimicrob Agents 2006;28:325-32.

3. Kramer JM, Hammill B, Anstrom KJ, Fetterolf D, Snyder R, Charde JP, Hoffman BS, Allen LaPointe N, Peterson E. National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance. Am Heart J 2006;152:454.e1-8.

4. Newby LK, LaPointe NM, Chen AY, Kramer JM, Hammill BG, DeLong ER, Muhlbaier LH, Califf RM. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation 2006;113:203-12.

5. Curtis JR, Olivieri J, Allison JJ, Gaffo A, Juarez L, Kovac SH, Person S, Saag KG. A group randomized trial to improve safe use of nonsteroidal antiinflammatory drugs. Am J Manag Care 2005;11:537-43.

6. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, Hall K, Ray WA. Major congenital malformations after first trimester exposure to ACE inhibitors. N Engl J Med 2006;354:2443-51.

7. Lagarde WH, Barrows FP, Davenport ML, Kang M, Guess HA, Calikoglu AS. Continuous subcutaneous glucose monitoring in children with type 1 diabetes mellitus: a single-blind, randomized, controlled trial. Pediatr Diabetes 2006;7:159-64.

8. Metlay JP, Fishman NO, Joffe M, Edelstein PH. Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults. Vaccine 2006;24:468-75.

9. Halpern SD, Asch DA, Shaked A, Stock P, Blumberg EA. Inadequate hepatitis B vaccination and post-exposure evaluation among transplant surgeons: prevalence, correlates, and implications. Ann Surg 2006;244:305-9.

10. LaPointe NM, DeLong ER, Chen A, Hammill BG, Muhlbaier LH, Califf RM, Kramer JM. Multifaceted intervention to promote betablocker use in heart failure. Am Heart J 2006;151:992-8.

11. Shatin D, Rawson NS, Curtis JR, Braun MM, Martin CK, Moreland LW, Becker AF, Patkar NM, Allison JJ, Saag KG. Documented tuberculin skin testing among infliximab users following a multi-modal risk communication interventions. Pharmacoepidemiol Drug Saf 2006;15:11-8.

12. Abdolrasulnia M, Weichold N, Shewchuk R, Saag K, Cobaugh DJ, LaCivita C, Weissman N, Allison J. Agreement between medical record documentation and patient-reported use of nonsteroidal antiinflammatory drugs. Am J Health Syst Pharm 2006;63:744-7.

13. Curtis JR, Westfall AO, Allison J, Freeman A, Kovac SH, Saag KG. Agreement and validity of pharmacy data versus self-report for use of osteoporosis medications among chronic glucocorticoid users. Pharmacoepidemiol Drug Saf 2006;15:710-8.

14. McPhillips HA, Stille CJ, Smith D, Hecht J, Pearson J, Stull J, Debellis K, Andrade S, Miller M, Kaushal R, Gurwitz J, Davis RL. Potential medication dosing errors in outpatient pediatrics. J Pediatr 2005;147:761-7.

15. Indik JH, Pearson EC, Fried K, Woosley RL. Bazett and Fridericia QT correction formulas interfere with measurement of drug induced changes in QT interval. Heart Rhythm 2006;3:1003-7.

16. Mikuls TR, Curtis JR, Allison JJ, Hicks RW, Saag KG. Medication errors with the use of allopurinol and colchicine: a retrospective study of a national, anonymous Internetaccessible error reporting system. J Rheumatol 2006;33:562-6.

17. Curtis JR, Westfall AO, Allison J, Bijlsma JW, Freeman A, George V, Kovac SH, Spettell CM, Saag KG. Population-based assessment of adverse events associated with longterm glucocorticoid use. Arthritis Rheum 2006;55:420-6.

18. Feldstein AC, Smith DH, Perrin N, Yang X, Simon SR, Krall M, Sittig DF, Ditmer D, Platt R, Soumerai SB. Reducing warfarin medication interactions: an interrupted time series evaluation. Arch Intern Med 2006;166:1009-15.

19. Abarca J, Malone DC, Skrepnek GH, Rehfeld RA, Murphy JE, Grizzle AJ, Armstrong EP, Woosley RL. Community pharmacy managers' perception of computerized drug-drug interaction alerts. J Am Pharm Assoc (Wash DC) 2006;46:148-53.

20. Murphy JE, Malone DC, Skrepnek GH, Armstrong EP, Abarca J, Grizzle AJ, Rehfeld RA, Woosley RL. The role of technicians in managing computerized drug-drug interaction alerts in community pharmacies and the relationship to pharmacist managers' attitudes. J Pharm Technol 2005;22:155-60.

21. Perkins NA, Murphy JE, Malone DC, Armstrong EP. Performance of drug-drug interaction software for personal digital assistants. Ann Pharmacother 2006;40:850-5.

22. Ko Y, Brown ML, Frost R, Woosley RL. Brief report: development of a prescription medication information webliography for consumers. J Gen Intern Med 2006;31:1313-6.

23. Ridley DB, Kramer JM, Tilson HH, Grabowski HG, Schulman KA. Spending on postapproval drug safety. Health Aff (Millwood) 2006;25:429-36.

24. Roblin DW, Platt R, Goodman MJ, Hsu J, Nelson WW, Smith DH, Andrade SE, Soumerai SB. Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: how much is too much? Med Care 2005;43:951-9.

25. Skrepnek GH, Abarca J, Malone DC, Armstrong EP, Shirazi FM, Woosley RL. Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs. Ann Pharmacother 2005;39:1785-91.

Additional Publications

Abdolrasulnia M, Weichold N, Shewchuk R, Saag K, Cobaugh DJ, LaCivita C, Weissman N, Allison J. Agreement between medical record documentation and patient reported use of nonsteroidal antiinflammatory drugs. Am J Health Syst Pharm 2006;63:744-7.

Albrecht SJ, Fishman NO, Kitchen J, Nachamkin I, Bilker WB, Hoegg C, Samuel C, Barbagallo S, Arentzen J, Lautenbach E. Reemergence of gram-negative health careassociated bloodstream infections. Arch Intern Med 2006;166:1289-94.

Allen LaPointe NM, Curtis LH, Chan KA, Kramer JM, Lafata JE, Gurwitz JH, Raebel MA, Platt R. Frequency of high-risk use of QT-prolonging medications. Pharmacoepidemiol Drug Saf 2006;15:361-8.

Apter AJ, Kinman JL, Bilker WB, Herlim M, Margolis DJ, Lautenbach E, Hennessy S, Strom BL. Is there crossreactivity between penicillins and cephalosporins? Am J Med 2006;119:354.e11-19.

Bradburn MJ, Deeks JJ, Berlin JA, Localio AR. Much ado about nothing: a comparison of the performance of metaanalytical methods with rare events. Stat Med 2007;26:53-77 (Published online April 2006).

Criswell LA, Saag KG, Mikuls TR, Cerhan JR, Merlino LA, Lum RF, Pfeiffer KA, Woehl B, Seldin MF. Smoking interacts with genetic risk factors in the development of rheumatoid arthritis among older Caucasian women. Ann Rheum Dis 2006;65:1163-7.

Curtis JR, Westfall AO, Allison JJ, Freeman A, Saag KG. Channeling and adherence with alendronate and risedronate among chronic glucocorticoid users. Osteoporos Int 2006;17:1268-74.

Gasink LB, Fishman NO, Weiner MG, Nachamkin I, Bilker WB, Lautenbach E. Fluoroquinolone-resistant Pseudomonas aeruginosa: assessment of risk factors and clinical impact. Am J Med 2006;119:526.e19-25.

Gross R, Zhang Y, Grossberg R. Medication refill logistics and refill adherence in HIV. Pharmacoepidemiol Drug Saf 2005;14:789-93.

Guess HA. Exposure-time varying hazard function ratios in case-control studies of drug effects. Pharmacoepidemiol Drug Saf 2006;15:81-92.

Harrold LR, Yood RA, Mikuls TR, Andrade SE, Davis J, Fuller J, Chan KA, Roblin D, Raebel MA, VonWorley A, Platt R, Saag KG. Sex differences in gout epidemiology: evaluation and treatment. Ann Rheum Dis 2006;65:1368-72 (Published online April 2006).

Hass DJ, Lewis JD. Quality of manufacturer provided information on safety and efficacy claims for dietary supplements for colonic health. Pharmacoepidemiol Drug Saf 2006;15:578-86.

Hicks RW, Becker SC, Cousins DD. Harmful medication errors in children: a 5-year analysis of data from the USP's MEDMARX program. J Pediatr Nurs 2006;21:290-8.

Katchman AN, Koerner J, Tosaka T, Woosley RL, Ebert SN. Comparative evaluation of HERG currents and QT intervals following challenge with suspected torsadogenic and nontorsadogenic drugs. J Pharmacol Exp Ther 2006;316:1098-106.

Kovac SH, Mikuls TR, Mudano A, Saag KG. Health related quality of life among self-reported arthritis sufferers: effects of race/ethnicity and residence. Qual Life Res 2006;15:451-60.

Lautenbach E, Fishman NO, Metlay JP, Mao X, Bilker WB, Tolomeo P, Nachamkin I. Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative. J Infect Dis 2006;194:79-85.

Lautenbach E, Metlay JP, Bilker WB, Edelstein PH, Fishman NO. Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy. Clin Infect Dis 2005;41:923-9.

Linkin DR, Paris S, Fishman NO, Metlay JP, Lautenbach E. Inaccurate communications in telephone calls to an antimicrobial stewardship program. Infect Control Hosp Epidemiol 2006;27:688-94.

Lipworth AD, Hyle EP, Fishman NO, Nachamkin I, Bilker WB, Marr AM, Larosa LA, Kasbekar N, Lautenbach E. Limiting the emergence of extended-spectrum Beta-lactamase-producing enterobacteriaceae: influence of patient population characteristics on the response to antimicrobial formulary interventions. Infect Control Hosp Epidemiol 2006;27:279-86.

Malone DC, Hutchins DS, Haupert H, Hansten P, Duncan B, Van Bergen RC, Solomon SL, Lipton RB. Assessment of potential drug-drug interactions with a prescription claims database. Am J Health Syst Pharm 2005;62:1983-91.

Mizuta M, Linkin DR, Nachamkin I, Fishman NO, Weiner MG, Sheridan A, Lautenbach E. Identification of optimal combinations for empirical dual antimicrobial therapy of Pseudomonas aeruginosa infection: potential role of a Combination Antibiogram. Infect Control Hosp Epidemiol 2006;27:413-5.

Pearson EC, Woosley RL. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system. Pharmacoepidemiol Drug Saf 2005;14:747-53.

Skrepnek GH, Armstrong EP, Malone DC, Abarca J, Murphy JE, Grizzle AJ, Rehfeld RA, Woosley RL. Workload and availability of technology in metropolitan community pharmacies. J Am Pharm Assoc (Wash DC) 2006;46:154-60.

Wagner AK, Chan KA, Dashevsky I, Raebel MA, Andrade SE, Lafata JE, Davis RL, Gurwitz JH, Soumerai SB, Platt R. FDA drug prescribing warnings: is the black box half empty or half full? Pharmacoepidemiol Drug Saf 2006;15:369-86.

Return to Contents

AHRQ Publication No. 09-0063
Current as of May 2009

Internet Citation:

Centers for Education and Research on Therapeutics (CERTs) Annual Report, Year 7. AHRQ Publication No. 09-0063, May 2009. Agency for Healthcare Research and Quality, Rockville, MD. http://certs.hhs.gov/about/annrpt7/annlrep7.htm